DNM1L and lung adenocarcinoma: We further used NCT503 to block PHGDH [37], the rate‐limiting enzyme of glycolytic serine synthesis, and evaluated the role of this adaptive response in the proliferation of DNM1L‐KO lung adenocarcinoma cell lines.